LITP yields 6.73% · JNJ yields 2.14%● Live data
📍 LITP pulled ahead of the other in Year 1
Combined, LITP + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LITP + JNJ for your $10,000?
LITP provides pure-play exposure to the global lithium industry in support of achieving a less carbon-intensive economy. The fund gives access to a portfolio of 40-50 US and foreign companies involved with or derive half of their revenue from the mining, exploration, development, or production of lithium. The investable universe is identified through a proprietary selection methodology which includes industry publication reviews and fundamental research. All eligible securities are then included as constituents provided that the minimum market-cap and liquidity requirements are met. An intensity score is also assigned to each company depending on their revenue percentage attributable to lithium. While the index is market cap-weighted, several capping rules are implemented based on the securities initial weights to ensure a diversified portfolio. Index reconstitution and rebalancing is done on a semi-annual basis in June and December.
Full LITP Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.